BioMarin Pharmaceutical Inc.
USD57.27
-0.40 (-0.69%)
CEO
Alexander Hardy
IPO Date
1999-07-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$57.92
Prev. Close
$57.67
Day Low
$57.19
Day High
$57.92
52W Low
$49.26
52W High
$66.28
Market Cap
$11.07B
Volume
0.05M
| 29.3 |
| 31 Dec 2023 | FY | 78.0% | 6.9% | 3.4% | 2.5% | 0.22 | 2.51 | 108.0 |
| 31 Dec 2022 | FY | 76.0% | 6.8% | 3.1% | 2.2% | 0.24 | 4.67 | 135.4 |
| 31 Dec 2021 | FY | 74.5% | -3.5% | -1.5% | -1.1% | 0.26 | 4.16 | -252.1 |
| 31 Dec 2020 | FY | 71.8% | 45.9% | 20.8% | 14.6% | 0.26 | 4.76 | 18.6 |
| 31 Dec 2019 | FY | 78.9% | -1.4% | -0.8% | -0.5% | 0.28 | 2.08 | -634.8 |
| 31 Dec 2018 | FY | 78.9% | -5.2% | -2.6% | -1.7% | 0.28 | 3.93 | -195.3 |
| 31 Dec 2017 | FY | 81.6% | -8.9% | -4.2% | -2.5% | 0.42 | 2.70 | -132.9 |
| 31 Dec 2016 | FY | 81.2% | -56.4% | -22.8% | -15.7% | 0.25 | 3.24 | -21.8 |
| -61.2 |
| 30 Sept 2025 | Q3 | 82.0% | -4.0% | -0.5% | -0.4% | 0.10 | 4.83 | -84.6 |
| 30 Jun 2025 | Q2 | 81.8% | 29.1% | 4.0% | 3.2% | 0.10 | 5.56 | 10.9 |
| 31 Mar 2025 | Q1 | 79.7% | 24.9% | 3.2% | 2.6% | 0.10 | 5.52 | 18.2 |
| 31 Dec 2024 | Q4 | 81.8% | 16.7% | 2.2% | 1.8% | 0.11 | 5.33 | 25.1 |
| 30 Sept 2024 | Q3 | 74.7% | 14.2% | 2.0% | 1.5% | 0.11 | 4.27 | 31.5 |
| 30 Jun 2024 | Q2 | 81.7% | 15.1% | 2.0% | 1.5% | 0.21 | 3.05 | 36.4 |
| 31 Mar 2024 | Q1 | 80.7% | 13.7% | 1.7% | 1.3% | 0.22 | 2.74 | 46.4 |
| 31 Dec 2023 | Q4 | 79.0% | 3.2% | 0.4% | 0.3% | 0.22 | 2.51 | 223.0 |